COVID-19-PCR Press Release

Now Offering COVID-19 PCR and Antibody Testing. Learn More

COVID-19-PCR Press Release

SpectraCell® is proud of the work we're doing to quickly mobilize our community to overcome the health crisis by increasing access to COVID-19 testing. We are now offering PCR molecular Testing on-site at SpectraCell Laboratories.

“Our main focus is to slow the spread of this virus. Until a vaccine is ready, the best action we can take is test as many people as possible and we have an obligation to do just that,” states Dr. Jonathan Stein, Chief Scientific Officer at SpectraCell® Laboratories.

PCR testing is the most common method for diagnosing an existing infection by the COVID-19 virus(called SARS-CoV-2). It is the technology used in this laboratory test, although this test is known by several names:

  • RT-PCR
  • Screening test
  • Molecular test or assay
  • Diagnostic test
  • Genetic test
  • Nasopharyngeal swab


Urgency in Fast and Reliable Test Results

Although access to COVID-19 testing has increased, long delays in test result turnaround time continues to hobble our nation’s coronavirus response. SpectraCell® is prepared to produce results for PCR testing within 48-72 hours. 

The patient’s sample will be collected (via nasopharyngeal swab) on-site at SpectraCell’s laboratory at 6030 North Course Drive, Houston, TX 77072. All necessary precautions for the safety of our staff and the community will be taken.

More information on ordering the COVID-19 PCR Test from SpectraCell® Laboratories can be found at


About SpectraCell Laboratories – SpectraCell is a CLIA accredited laboratory that provides advanced clinical testing to healthcare providers and consumers nationwide. Established in 1993 with its flagship Micronutrient Test that assesses micronutrient deficiencies, immune response and metabolic function in a person at the cellular level, SpectraCell has since become a leader in functional testing and serves over 6000 physicians in the United States.